MedTrace Logo

Neuroinflammation and Bispectral Index After Subarachnoid Hemorrhage

NCT01516671 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2013-11-13

No results posted yet for this study

Summary

Subarachnoid hemorrhage (SAH) is associated with a high mortality and frequently leads to severe disability in survivors caused by cerebral vasospasm and infarction.

This study aims to elucidate the role of neuroinflammation (endocannabinoids and cortisol levels in cerebrospinal fluid) in the pathophysiology of cerebral vasospasm and the value of the bilateral bispectral index (BIS) for the early diagnosis of cerebral vasospasm.

Conditions

  • Subarachnoid Hemorrhage

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Volker Huge, MD · Klinikum der Universität München, Ludwig-Maximilians-University, Department of Anaesthesiology

  • Cyrill Hornuss, MD · Klinikum der Universität München, Ludwig-Maximilians-University, Department of Anaesthesiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01516671 on ClinicalTrials.gov